Corticosteroid in Septic Shock: Advantage or Disadvantage?


  • Sakura Muhammad Tola


sepsis, septic shock, hydrocortisone


Sepsis has become a major health issue, with more patients dying in hospitals due to sepsis related complications. The pathogenesis of sepsis is complex and involves multiple aspects of the interaction between the infecting microorganisms and the host. Sepsis is fundamentally an inflammatory disease mediated by the activation of the innate immune system. In the case, sepsis is an unbalanced (proinflammatory and anti-inflammatory), dysregulated response, the localized process goes out of control and becomes systemic contribute to diminished oxygen delivery. The process also leads to decreased hemodynamic stability, hyperglycemia and ultimately, multi organ dysfunction syndrome and death in septic shock. The use of corticosteroid hydrocortisone as adjunctive therapy is still debating due to the lack of supporting study and differences result among the studies.


Angus, DC, van der Poll T. 2013. Severe Sepsis and Septic Shock. N Engl J Med 369:840-51.

Annane, D., Renault, A., Brun-Buisson, C., Megarbane, B., Quenot, J.P., Siami, S. 2018. e Hydrocortisone plus Fludrocortisone for Adults with Septic Shock. N Engl J Med. 378(9):809-8.

Cohen, J., Venkatesh, B. 2019. Adjunctive Corticosteroid Treatment in Septic Shock. Anesthesiology. 131:410-9.

Dellinge,r RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. 2013. Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock: 2012. Crit Care Med. 41:580-637.

Gupta, P, Bhatia, V. 2008. Corticosteroid Physiology and Principles of Therapy. Indian J Pediatr. 75 (10) : 1039-1044.

Hotchkiss, R.S., Moldawer, L.L., Opal, S.M., Reinhart, K., Turnbull, I.R., Vincent. J.L. 2017. Sepsis and septic shock. Nat Rev Dis Primers. Author manuscript; available in PMC 2017 August 01.

Ibarra-Estrada, M.A., Chávez-Peña, Q., Reynoso-Estrella, C.I., Rios-Zermeño, J., Aguilera-González, P.E., García-Soto, M.A., et al. 2017. Timing, method and discontinuation of hydrocortisone administration for septic shock patients. World J Crit Care Med 6:1:65-73

Keeley, A., Hine, P., Nsutebu, E. 2017. The recognition and management of sepsis and septic shock: a guide for non-intensivists. Postgrad Med J;93:626-634.

King, E.G., Bauza, G.J., Mella, J.R., Remick, D.G. Pathophysiologic mechanisms in septic shock. Laboratory Investigation 2014;94:4-12.

Lian, XJ, Huang, DZ, Cao, YS, Wei, YX, Lian ZZ, Qin TH, et al. 2019. Reevaluating the Role of Corticosteroids in Septic Shock: An Updated Meta-Analysis of Randomized Controlled Trials. BioMed Research International. Article ID 3175047, 14 pages 2019/3175047.

Rhee, C, Jones, TM, Hamad, Y, Pande ,A, Varon, J, O Brien, C, et al. 2019. Prevalence, Underlying Causes, and Preventability of Sepsis-Associated Mortality in US Acute Care Hospitals. JAMA Netw Open. 2(2):e187571.

Rhodes, A., Evans, L.E., Alhazzani, W., et al. 2017. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Crit Care Med 2017;45:486-552. 10.1097/CCM.0000000000002255.

Salomao, R., Ferreira, B.L., Salomao, M.C., Santos, S.S., Azevedo, L.C.P., Brunialti, M.K.C. 2019. Sepsis: evolving concepts and challenges. Brazilian Journal of Medical and Biological Research 52(4): e8595.

Sprung, CL, Annane, D, Keh, D, Moreno, R, Singe,r M, Freivogel, K, et al. 2008. Hydrocortisone Therapy for Patients with Septic Shock. N Engl J Med. 358:111-24.

Thompson, K, Venkatesh, B, Finfer, S. 2019. Sepsis and septic shock: current approaches to management. Internal Medicine Journal 49:160-170.

Venkatesh, B, Finfer, S, Myburgh, J, Cohen, J, Billot, L. 2018. Long-term outcomes of the ADRENAL Trial. N Engl J Med. 378:1744–5.

Wadelek, J. 2017. Diagnosis and Treatment of Patients in Septic Shock. New Med. 21(1): 31-36.




How to Cite

Tola, S. M. (2019). Corticosteroid in Septic Shock: Advantage or Disadvantage?. Majalah Sainstekes, 6(2).